Osmohale (Mannitol)

Mannitol, the active ingredient in Osmohale, is an osmotic diuretic presented as an inhalation solution for inhalation use. It is used to support renal function and manage fluid balance in patients requiring renal support. GNH USA supplies Osmohale as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, transplant centres and pharmacies worldwide.

GNH USA supplies Osmohale as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, transplant centres and pharmacies worldwide.

Osmohale is an osmotic diuretic that acts on renal pathways to promote diuresis and assist in fluid management.

- Acute kidney injury: helps facilitate urine output and reduce fluid overload. - Chronic kidney disease: supports maintenance of fluid balance during disease progression. - Pre‑operative preparation: used to reduce intravascular volume before certain surgical procedures. - Hyper‑glucose management in diabetes (though it is off‑label but recognised in some guidelines). - Treatment of intrarenal pressure increase during contrast enhanced imaging procedures to protect renal function and reduce risk of contrast‑induced nephropathy.

Mannitol may produce a range of adverse reactions, from mild to serious, depending on patient factors and dosing.

Common Side Effects: - Headache  - Nausea  - Thirst  - Transient rise in blood pressure  - Electrolyte imbalance (e.g., hyponatremia) - Mild cough due to inhalation formulation

Serious or Rare Side Effects: - Pulmonary edema  - Severe hypotension or hypertensive crisis  - Acute renal failure in susceptible patients  - Anaphylactic reaction to formulation excipients  - Metabolic acidosis  - Hyperosmolar syndrome 

When cautious st  ​      

-      t   t  ewline  ewline   ewline

ewline     ewline \

??